LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.45 | 21.74 | 5441 | 6023 | 0.9033 | 0.9751 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 57.45 | 21.74 | 5478 | 6023 | 0.9094 | 0.9767 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 59.42 | 21.74 | 4804 | 6125 | 0.7843 | 0.9412 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 59.42 | 21.74 | 4848 | 6125 | 0.7915 | 0.9433 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 59.42 | 21.74 | 5709 | 6125 | 0.9320 | 0.9828 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 59.42 | 21.74 | 5829 | 6125 | 0.9516 | 0.9879 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.39 | 21.74 | 5116 | 6112 | 0.8369 | 0.9567 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.39 | 21.74 | 5155 | 6112 | 0.8433 | 0.9585 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.39 | 21.74 | 6105 | 6112 | 0.9987 | 0.9997 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.39 | 21.74 | 6144 | 6112 | 1.0051 | 1.0013 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.36 | 21.74 | 5402 | 6191 | 0.8726 | 0.9668 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.36 | 21.74 | 5431 | 6191 | 0.8772 | 0.9681 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.36 | 21.74 | 6419 | 6191 | 1.0368 | 1.0089 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 64.36 | 21.74 | 6467 | 6191 | 1.0446 | 1.0107 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.33 | 21.74 | 5661 | 6235 | 0.9079 | 0.9765 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.33 | 21.74 | 5697 | 6235 | 0.9136 | 0.9780 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.33 | 21.74 | 6658 | 6235 | 1.0677 | 1.0161 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 66.33 | 21.74 | 6705 | 6235 | 1.0753 | 1.0179 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.30 | 21.74 | 5872 | 6244 | 0.9403 | 0.9850 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.30 | 21.74 | 5939 | 6244 | 0.9511 | 0.9878 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.30 | 21.74 | 6932 | 6244 | 1.1101 | 1.0257 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 68.30 | 21.74 | 6985 | 6244 | 1.1186 | 1.0276 | MN20160310_N01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.27 | 21.74 | 6071 | 6201 | 0.9789 | 0.9948 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.27 | 21.74 | 6160 | 6201 | 0.9932 | 0.9983 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.27 | 21.74 | 7181 | 6201 | 1.1579 | 1.0363 | MN20160310_N01 | N08 |